Niagen Bioscience Inc

NASDAQ:NAGE

Biotechnology

Healthcare
$1.94 +3.31%

+$0.11 today

Market cap
$153.64M
Beta
2.06
P/E (TTM)
14.9
EPS (TTM)
$0.23
52W Low $3.35High $14.69

Volume 0.52M

Average 0.86M

Income Statement

Follow revenue through to earnings.

Revenue

$129.42M

FY 2025 · Annual

+29.9% YoY

Operating Income

$14.30M

FY 2025 · Annual

+85.0% YoY

Net Income

$17.38M

FY 2025 · Annual

+103.3% YoY

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue67.45M72.05M83.57M99.6M129.42M
Cost of Revenue25.96M29.25M32.79M38.01M46.23M
Gross Profit41.49M42.8M50.78M61.59M83.19M
Gross Margin61.5%59.4%60.8%61.8%64.3%
Research & Development3.83M4.83M4.96M6.02M6.33M
Selling, General & Admin64.73M56.6M51.42M47.84M62.56M
Operating Expenses68.56M61.43M56.38M53.86M68.89M
Depreciation & Amortization1.63M1.88M1.71M1.48M1.45M
EBITDA(25.45M)(14.66M)(3.23M)10.34M19.64M
EBITDA Margin-37.7%-20.3%-3.9%10.4%15.2%
Operating Income(27.07M)(18.63M)(5.6M)7.73M14.3M
Operating Margin-40.1%-25.9%-6.7%7.8%11.0%
Interest Income03K661K1.13M2.13M
Interest Expense55K0000
Other Income / Expenses(55K)2.09M661K1.13M3.9M
Income Before Tax(27.13M)(16.54M)(4.94M)8.86M18.19M
Pre-Tax Margin-40.2%-23.0%-5.9%8.9%14.1%
Income Tax Expense000305K810K
Net Income(27.13M)(16.54M)(4.94M)8.55M17.38M
Net Margin-40.2%-23.0%-5.9%8.6%13.4%
EPS (Basic)(0.40)(0.24)(0.07)0.100.22
EPS (Diluted)(0.40)(0.24)(0.07)0.110.20
Weighted Avg Shares67.19M68.92M70.54M85.42M79.18M
Weighted Avg Shares (Diluted)67.19M69.73M74.99M79.72M85.44M

NAGE Earnings Waterfall · TTM

NASDAQ:NAGE · Revenue to Net Income

Key Ratios

EPS$0.22
Gross Margin64.3%
Net Margin14.3%
P/E Ratio42.5
P/S Ratio22.0

Analysis

$130.4M of revenue converted into $18.6M of net income for the selected period. Gross margin is 64.3% and net margin is 14.3%, showing how much revenue survives after costs and taxes. EPS is $0.22, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026

How much revenue does NAGE generate?

Niagen Bioscience Inc (NAGE) reported $129.42M of revenue in fiscal 2025.

Is NAGE profitable?

Niagen Bioscience Inc (NAGE) reported $17.38M of net income, with a net margin of 13.4%.